Evidence map›Paper›PMID 28746363›Full record

ArticlePloS one2017

MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.

Manuel Hora, Riddhiman Sarkar, Vanessa Morris, Kai Xue, Elke Prade, Emma Harding, Johannes Buchner, Bernd Reif

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2023
    Article
  4. Getting Smaller by Denaturation: Acid-Induced Compaction of Antibodies.The journal of physical chemistry letters · 2023
    Article
  5. Article
  6. Solid-state NMR spectroscopy.Nature reviews. Methods primers · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manuel HoraMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.ORCID http://orcid.org/0000-0002-5156-0687
Riddhiman SarkarMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Vanessa MorrisMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Kai XueMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Elke PradeMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Emma HardingMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Johannes BuchnerMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.
Bernd ReifMunich Center for Integrated Protein Science (CIPS-M) at Department Chemie, Technische Universität München (TUM), Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little structural information is available so far on amyloid fibrils consisting of immunoglobulin light chains. It is not understood which features of the primary sequence of the protein result in fibril formation. We report here MAS solid-state NMR studies to identify the structured core of κ-type variable domain light chain fibrils. The core contains residues of the CDR2 and the β-strands D, E, F and G of the native immunoglobulin fold. The assigned core region of the fibril is distinct in comparison to the core identified in a previous solid-state NMR study on AL-09 by Piehl at. al, suggesting that VL fibrils can adopt different topologies. In addition, we investigated a soluble oligomeric intermediate state, previously termed the alternatively folded state (AFS), using NMR and FTIR spectroscopy. The NMR oligomer spectra display a high degree of similarity when compared to the fibril spectra, indicating a high structural similarity of the two aggregation states. Based on comparison to the native state NMR chemical shifts, we suggest that fibril formation via domain-swapping seems unlikely. Moreover, we used our results to test the quality of different amyloid prediction algorithms.

Indexed as

Protein MultimerizationAmyloidHumansImmunoglobulin Light ChainsImmunoglobulin Variable RegionKineticsMagnetic Resonance SpectroscopyMicroscopy, Electron, TransmissionModels, MolecularMutationProtein ConformationProtein PrecursorsRecombinant ProteinsSpectroscopy, Fourier Transform InfraredAmyloidImmunoglobulin Light ChainsImmunoglobulin Variable RegionProtein PrecursorsRecombinant Proteins

Identifiers

PMID28746363
PMCPMC5528828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.